| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/06/2004 | WO2004038371A2 Ccr8 as modifier of branching morphogenesis and methods of use |
| 05/06/2004 | WO2004038370A2 Enhancing the sensitivity of a microsphere sensor |
| 05/06/2004 | WO2004038369A2 Ip3 protein binding assay |
| 05/06/2004 | WO2004038368A2 Device and method for monitoring leukocyte migration |
| 05/06/2004 | WO2004038367A2 Biological assays using gradients formed in microfluidic systems |
| 05/06/2004 | WO2004038364A2 In line test device and methods of use |
| 05/06/2004 | WO2004038363A2 Microfluidic device and method for pressure-driven plug transport and reaction |
| 05/06/2004 | WO2004038361A1 Test device for internal combustion engine |
| 05/06/2004 | WO2004038045A2 Method for diagnosing diffuse-type gastric cancer |
| 05/06/2004 | WO2004038041A1 Screening assay to identify inhibitors of the murd enzyme using an activator-independent murd enzyme |
| 05/06/2004 | WO2004038040A2 Enzyme array and assay |
| 05/06/2004 | WO2004038036A2 Methods of assaying for modulators of the inflammatory process using components of the ubiquitin ligation cascade |
| 05/06/2004 | WO2004038034A1 Novel fructosyl peptide oxidase and utilization thereof |
| 05/06/2004 | WO2004038033A1 Defructosylation method |
| 05/06/2004 | WO2004038028A2 Hepatitis x virus antigen |
| 05/06/2004 | WO2004038018A1 Gene expressed specifically in dopamine-producing neuron precursor cells after termination of division |
| 05/06/2004 | WO2004038005A2 Methods of identifying reduced internalization transmembrane receptor agonists |
| 05/06/2004 | WO2004038003A2 Human polypeptides encoded by polynucleotides and methods of their use |
| 05/06/2004 | WO2004037996A2 Evaluation of breast cancer states and outcomes using gene expression profiles |
| 05/06/2004 | WO2004037992A2 Mapk7 as modifier of branching morphogenesis and methods of use |
| 05/06/2004 | WO2004037991A2 Prkcb1 as modifier of branching morphogenesis and methods of use |
| 05/06/2004 | WO2004037986A2 Map2k6 as modifier of branching morphogenensis and methods of use |
| 05/06/2004 | WO2004037985A2 Modulation of g protein coupled receptor activity |
| 05/06/2004 | WO2004037972A2 Endogenous retrovirus up-regulated in prostate cancer |
| 05/06/2004 | WO2004037850A2 Multi-sided immersion formation of composite structures and method |
| 05/06/2004 | WO2004037848A2 Process for determining target function and identifying drug leads |
| 05/06/2004 | WO2004037371A2 Assay for determining the activity of fatty acid amide hydrolase |
| 05/06/2004 | WO2004037298A1 Method for determining gastric evacuation using a 13c-labelled test meal |
| 05/06/2004 | WO2004037278A2 Delocalization molecules and use thereof |
| 05/06/2004 | WO2004037206A2 Methods for diagnosing and treating pre-term labor |
| 05/06/2004 | WO2004037204A2 Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease |
| 05/06/2004 | WO2004037200A2 Reticulocyte depletion signatures |
| 05/06/2004 | WO2004037189A2 Methods for vaccinating against malaria |
| 05/06/2004 | WO2004037162A2 Compositions and methods for the treatment of hepatitis c virus infection |
| 05/06/2004 | WO2004037073A2 Inflammatory bowel disease and irritable bowel syndrome ibd-first chek diagnostic panel |
| 05/06/2004 | WO2004027427A8 Assays for fprl-1 ligands |
| 05/06/2004 | WO2004025563B1 Diffraction grating-based encoded micro-particles for multiplexed experiments |
| 05/06/2004 | WO2004023137A3 Method for screening for mutant virus movement proteins (mp) |
| 05/06/2004 | WO2004021008A3 Methods for detecting breast and ovarian cancer |
| 05/06/2004 | WO2004019976A3 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 05/06/2004 | WO2004019004A3 An arsenic meter |
| 05/06/2004 | WO2004018994A3 Method of analyzing the constituents of air extracted from the interior of a piece of baggage |
| 05/06/2004 | WO2004018100A3 A testing device for testing or analysing fluids and a holder and a storage container for such devices |
| 05/06/2004 | WO2004017895A3 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 05/06/2004 | WO2004017423A3 Sensor arrangement |
| 05/06/2004 | WO2004017356A3 Process and apparatus for pulsed dc magnetron reactive sputtering of thin film coatings on large substrates using smaller sputter cathodes |
| 05/06/2004 | WO2004015416A3 Methods for the identification of agents with anti-microbial action |
| 05/06/2004 | WO2004015090A3 Innervated artificial tissues and uses thereof |
| 05/06/2004 | WO2004013629A3 Screening for agents suitable for treatment of leukocyte associated inflammatory diseases |
| 05/06/2004 | WO2004013605A3 Nanoparticles comprising a mixed monolayer for specific ligand binding |
| 05/06/2004 | WO2004011676A3 Multi-reporter gene model for toxicological screening |
| 05/06/2004 | WO2004010676A3 System of measuring the quality of an environment and a local beacon therefor |
| 05/06/2004 | WO2004010139A3 Method for identifying biologically active compounds with anti-asthmatic, anti-allergic and/or immunosuppressive properties |
| 05/06/2004 | WO2004010074A3 Biosensor arrays and methods |
| 05/06/2004 | WO2004009787A3 Method and apparatus for manipulating polarizable analytes via dielectrophoresis |
| 05/06/2004 | WO2004008140A3 Plasma urotensin in human heart failure |
| 05/06/2004 | WO2004005928A3 Agents and methods for diagnosis and therapy of cancer and cancer risk assessment |
| 05/06/2004 | WO2004005918A3 Characterization of biochips containing self-assembled monolayers with maldi-tof-ms |
| 05/06/2004 | WO2004003562A3 Oncolytic viruses as phenotyping agents for neoplasms |
| 05/06/2004 | WO2004001367A3 Test system for identifying cancerous diseases |
| 05/06/2004 | WO2004001068A3 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 05/06/2004 | WO2003105891A3 Use of hec1 antagonists in the treatment of proliferative disorders and cancer |
| 05/06/2004 | WO2003102154A3 Improved receptor detection |
| 05/06/2004 | WO2003100028A3 Tr2, tr4, tr2/tr4 double knockouts and uses thereof |
| 05/06/2004 | WO2003099997A3 Methods and compositions for regulation and manipulation of steroidogenesis |
| 05/06/2004 | WO2003099318A3 Pancreas-specific proteins |
| 05/06/2004 | WO2003089922A8 Method for detecting ligands and targets in a mixture |
| 05/06/2004 | WO2003088910A3 Methods of assaying for cell cycle modulators |
| 05/06/2004 | WO2003087833A3 A marker for measuring liver cirrhosis |
| 05/06/2004 | WO2003083477A3 Active solid support and method for surface immobilization of combinatorial compounds or libraries |
| 05/06/2004 | WO2003075010A3 Non-peptide immunologic tracer precursors comprising a tyrosyl-(x)n or lysine-(x)n tyrosine motif |
| 05/06/2004 | WO2003074671A3 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 05/06/2004 | WO2003073105A9 Use of plag1 and plagl2 in cancer diagnosis and drug screening |
| 05/06/2004 | WO2003073063A3 Modulating insulin receptor signaling through targeting helic1 |
| 05/06/2004 | WO2003072801A3 Compositions and method for regulation of calcium-dependent signalling in brain |
| 05/06/2004 | WO2003060513A3 Method and apparatus for cancer detection |
| 05/06/2004 | WO2003057156A3 Epithelial cell lines from gene knockout mice and methods of use thereof |
| 05/06/2004 | WO2003050502A9 Prospective identification and characterization of breast cancer stem cells |
| 05/06/2004 | WO2003042702A3 Method for the identification of pharmacophores |
| 05/06/2004 | WO2003040679A3 Reversibly binding a fluorophore to a surface for the purpose of detecting ligate/ligand association events by fluorescence quenching |
| 05/06/2004 | WO2003040435A3 Rhodium electrocatalyst and method of preparation |
| 05/06/2004 | WO2003031567A9 Precursor conversion screening methods |
| 05/06/2004 | WO2003027631A3 Muscle sample prepared for prion assay |
| 05/06/2004 | WO2003025575A8 Methods and compositions involving thymidine phosphorylase as a marker for hiv infection, aids progression, and drug resistance |
| 05/06/2004 | WO2003022298A3 Use of a protein of the crmp family for treating diseases related to the immune system |
| 05/06/2004 | WO2003019197A3 Diabetic model |
| 05/06/2004 | WO2002100801A3 Method for reversible immobilisation of biological macromolecules and device therefor |
| 05/06/2004 | WO2002092788A9 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 05/06/2004 | WO2002079755A3 Detection and amplification of ligands |
| 05/06/2004 | WO2002079387A9 Modular molecular clasps and uses thereof |
| 05/06/2004 | WO2002075609A9 Predicting metabolic stability of drug molecules |
| 05/06/2004 | WO2002074914A3 Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts |
| 05/06/2004 | WO2002074251A9 Monoclonal antibody therapy for pancreas cancer |
| 05/06/2004 | WO2002068462A9 Internal standard for electrophoretic and chromatographic separation processes |
| 05/06/2004 | WO2002042735A3 Human kcr1 regulation of herg potassium channel block |
| 05/06/2004 | WO2002042734A3 Mems-based integrated magnetic particle identification system |
| 05/06/2004 | WO2002038108A3 Methods of treating disorders related to apoe |
| 05/06/2004 | WO2002037121A3 Detection of modified amino acids by mass spectrometry |
| 05/06/2004 | US20040088118 Method for generating a hierarchical topologican tree of 2d or 3d-structural formulas of chemical compounds for property optimisation of chemical compounds |
| 05/06/2004 | US20040088116 Methods and systems for creating and using comprehensive and data-driven simulations of biological systems for pharmacological and industrial applications |